These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20558585)

  • 41. A Francisella tularensis SCHU S4 mutant deficient in γ-glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate.
    Ireland PM; LeButt H; Thomas RM; Oyston PCF
    Microbiology (Reading); 2011 Nov; 157(Pt 11):3172-3179. PubMed ID: 21852349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PATHOGENESIS AND IMMUNE RESPONSES OF FRANCISELLA TULARENSIS STRAINS IN WILD-CAUGHT COTTONTAIL RABBITS (SYLVILAGUS SPP.).
    Brown VR; Adney DR; Bielefeldt-Ohmann H; Gordy PW; Felix TA; Olea-Popelka FJ; Bowen RA
    J Wildl Dis; 2015 Jul; 51(3):564-75. PubMed ID: 25984770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pullulanase Is Necessary for the Efficient Intracellular Growth of Francisella tularensis.
    Uda A; Sharma N; Takimoto K; Deyu T; Koyama Y; Park ES; Fujita O; Hotta A; Morikawa S
    PLoS One; 2016; 11(7):e0159740. PubMed ID: 27448164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphotoxin-alpha plays only a minor role in host resistance to respiratory infection with virulent type A Francisella tularensis in mice.
    Zhang D; Kuolee R; Harris G; Zhang Q; Conlan JW; Chen W
    Mediators Inflamm; 2008; 2008():239740. PubMed ID: 18769490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.
    Guina T; Lanning LL; Omland KS; Williams MS; Wolfraim LA; Heyse SP; Houchens CR; Sanz P; Hewitt JA
    Front Cell Infect Microbiol; 2018; 8():99. PubMed ID: 29670861
    [No Abstract]   [Full Text] [Related]  

  • 46. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS.
    López MC; Duckett NS; Baron SD; Metzger DW
    Cell Immunol; 2004; 232(1-2):75-85. PubMed ID: 15922718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 49. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B.
    Fritz DL; England MJ; Miller L; Waag DM
    Comp Med; 2014 Oct; 64(5):341-50. PubMed ID: 25402174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.
    Anthony LS; Kongshavn PA
    Microb Pathog; 1987 Jan; 2(1):3-14. PubMed ID: 3507552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tularemia progression accompanied with oxidative stress and antioxidant alteration in spleen and liver of BALB/c mice.
    Pohanka M; Pavlis O; Ruttkay-Nedecky B; Sochor J; Sobotka J; Pikula J; Adam V; Kizek R
    J Microbiol; 2012 Jun; 50(3):401-8. PubMed ID: 22752903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.
    D'Elia R; Jenner DC; Laws TR; Stokes MG; Jackson MC; Essex-Lopresti AE; Atkins HS
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):348-61. PubMed ID: 21569124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.
    Stenmark S; Lindgren H; Tärnvik A; Sjöstedt A
    Microb Pathog; 2003 Aug; 35(2):73-80. PubMed ID: 12901846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Septic pneumonic tularaemia caused by Francisella tularensis subsp. holarctica biovar II.
    Fritzsch J; Splettstoesser WD
    J Med Microbiol; 2010 Sep; 59(Pt 9):1123-1125. PubMed ID: 20522628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis.
    Prior JL; Prior RG; Hitchen PG; Diaper H; Griffin KF; Morris HR; Dell A; Titball RW
    J Med Microbiol; 2003 Oct; 52(Pt 10):845-851. PubMed ID: 12972577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathology of natural Francisella tularensis subsp. holarctica infection in two yellow-necked mice (Apodemus flavicollis).
    Hestvik G; Uhlhorn H; Mattsson R; Westergren E; Södersten F; Åkerström S; Gavier-Widén D
    Acta Vet Scand; 2018 May; 60(1):26. PubMed ID: 29716621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The immunological efficacy of Francisella tularensis outer membranes for hamadryas baboons].
    Khlebnikov VS; Golovlev IR; Zhemchugov VE; Chugunov AM; Averin SF; Afanas'ev SS; Kalachev IIa; Pchelintsev SIu; Kislichkin NN
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):61-4. PubMed ID: 7941871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody.
    Klimpel GR; Eaves-Pyles T; Moen ST; Taormina J; Peterson JW; Chopra AK; Niesel DW; Carness P; Haithcoat JL; Kirtley M; Nasr AB
    Vaccine; 2008 Dec; 26(52):6874-82. PubMed ID: 18930100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
    Cong Y; Yu JJ; Guentzel MN; Berton MT; Seshu J; Klose KE; Arulanandam BP
    Vaccine; 2009 Sep; 27(41):5554-61. PubMed ID: 19651173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.